Literature DB >> 2118117

Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease.

A Lobo-Yeo1, G Senaldi, B Portmann, A P Mowat, G Mieli-Vergani, D Vergani.   

Abstract

Controversy exists regarding major histocompatibility complex antigen expression on hepatocytes. In this study, hepatocyte expression of class I and II major histocompatibility complex antigens was investigated in diseased and normal livers, using indirect immunofluorescent staining of mechanically isolated, viable hepatocytes. Hepatocytes were obtained from 76 children: 10 with autoimmune chronic active hepatitis, nine with primary sclerosing cholangitis, nine with chronic hepatitis B virus infection, five after liver transplantation, 19 with extrahepatic biliary atresia, 11 with alpha 1-antitrypsin deficiency, four with idiopathic neonatal hepatitis and nine with histologically normal liver. Immunohistochemistry was performed in all cases; flow cytofluorimetry was performed for class I antigens in 38 cases and performed for class II antigens in 18 cases. From three children with autoimmune chronic active hepatitis and two with chronic hepatitis B virus infection, isolated hepatocytes were also incubated with gamma-interferon before staining and analysis. By fluorescence microscopy, class I antigens were detected on hepatocytes from all children, the highest percentage (100%) of positive cells and the most intense staining were observed in untreated patients with autoimmune chronic active hepatitis or primary sclerosing cholangitis and in those with acute rejection of a liver transplant. Reduced class I antigen expression occurred in chronic hepatitis B virus infection. Class II antigens were only detected on hepatocytes from eight patients: three with autoimmune chronic active hepatitis and five with primary sclerosing cholangitis, all untreated. Flow cytofluorimetric analysis confirmed the results obtained by fluorescence microscopy, but it also demonstrated a weak class II antigen expression during liver allograft rejection.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118117     DOI: 10.1002/hep.1840120208

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  18 in total

1.  Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model.

Authors:  Taisuke Ito; Natsuho Ito; Albrecht Bettermann; Yoshiki Tokura; Masahiro Takigawa; Ralf Paus
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

Review 2.  Autoimmune hepatitis.

Authors:  G Mieli-Vergani; D Vergani
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

Review 3.  Cutting edge issues in autoimmune hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

4.  Serum beta2-microglobulin in chronic hepatitis C.

Authors:  M Malaguarnera; S Restuccia; I Di Fazio; A M Zoccolo; B A Trovato; G Pistone
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

Review 5.  Cell mediators of autoimmune hepatitis and their therapeutic implications.

Authors:  Aldo J Montano-Loza; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

6.  Expression rate of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B.

Authors:  R Fukuda; S Satoh; X T Nguyen; Y Uchida; N Kohge; S Akagi; S Ikeda; M Watanabe; S Fukumoto
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

Review 7.  Autoimmune hepatitis.

Authors:  Diego Vergani; Maria Serena Longhi; Dimitrios P Bogdanos; Yun Ma; Giorgina Mieli-Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

8.  Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro.

Authors:  H Löhr; U Treichel; T Poralla; M Manns; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

9.  Imaging effector functions of human cytotoxic CD4+ T cells specific for Plasmodium falciparum circumsporozoite protein.

Authors:  Ute Frevert; Alberto Moreno; J Mauricio Calvo-Calle; Christian Klotz; Elizabeth Nardin
Journal:  Int J Parasitol       Date:  2008-08-06       Impact factor: 3.981

10.  Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case report.

Authors:  Martin H Bluth; Stephan Kohlhoff; Kevin B Norowitz; Jonathan I Silverberg; Seto Chice; M Nowakowski; Helen G Durkin; Tamar A Smith-Norowitz
Journal:  Int J Med Sci       Date:  2009-06-30       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.